CO-PRESENTING PARTNERS
LIVE COVERAGE AND VIDEO PARTNERS
PARTNERS
CO-PRESENTING PARTNERS
LIVE COVERAGE AND VIDEO PARTNERS
PARTNERS
Jan 18, 2023 06:07 PM ISTMotilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 780 in its research report dated January 18, 2023.
Jan 18, 2023 11:34 AM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated January 18, 2023.
Oct 25, 2022 02:34 PM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated October 25, 2022.
Aug 09, 2022 10:56 AM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 825 in its research report dated August 08, 2022.
May 17, 2022 07:59 PM IST Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 16, 2022.
May 07, 2022 01:32 PM IST Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 05, 2022.
May 07, 2022 09:54 AM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 850 in its research report dated May 05, 2022.
Dec 28, 2021 02:01 PM IST Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated December 27, 2021.
Dec 06, 2021 01:54 PM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 954 in its research report dated December 06, 2021.
Feb 05, 2021 08:57 PM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 666 in its research report dated January 28, 2021.
Nov 06, 2020 04:39 PM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 671 in its research report dated November 03, 2020.
Aug 08, 2020 12:33 PM IST Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 576 in its research report dated August 05, 2020.
Jun 04, 2020 01:26 PM IST Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 576 in its research report dated Jun 03, 2020.
Nov 08, 2019 11:53 AM IST Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated November 07, 2019.
Jul 31, 2019 11:23 AM IST Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 459 in its research report dated July 29, 2019.
Jan 30, 2019 12:17 PM IST Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 695 in its research report dated January 29, 2019.
Nov 14, 2018 05:12 PM IST Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 704 in its research report dated November 05, 2018.
Jun 01, 2018 04:31 PM IST Prabhudas Lilladher recommended accumulate rating on Eris Lifesciences with a target price of Rs 885 in its research report dated May 28, 2018.
Oct 30, 2017 04:34 PM IST Bonanza is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 686 in its research report dated October 26, 2017.
Aug 24, 2017 03:11 PM IST Axis Direct is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 730 in its research report dated 23 August 2017.
Jun 16, 2017 10:01 AM IST With a predominant focus on the domestic formulations market, a robust portfolio of largely prescription-based drugs, and a tilt towards a promising chronic portfolio, the company seems fundamentally strong.
